Hi, I don't know the answer -- but since both CML and Gleevec toxicity produce anemia because of marrow suppression, maybe it's not possible to tell the difference. E.g., both would show a low reticulocyte count.
This full text paper on anemia from Gleevec https://onlinelibrary.wiley.com/doi/full/10.1002/ajh.23879 shows that other signs such as red blood cell size can vary, so that doesn't seem to help. Sorry.
Is it possible that after taking gleevec for only two weeks WBC droped from 36.7 to 7? All other blood counts are also came back to normal range. Could doctor make mistake in diagnosis of CML? Maybe I should get seg second opinion?
I was diagnosed with CML and given Gleevec 400 ml. After taking gleevec for 2 weeks doctor took additional blood test. My WBC dropped from 36.5 to 7.1 and all other blood counts came down to normal range. I'm wondering if gleevec could give such fast hematological response or I was possibly misdiagnosed originally. I don't and didn't have any symptoms, my spleen and liver weren't enlarged, no enlarged lymph. Should I get second opinion asap? Please, help me.
After two weeks on 400mlg gleevec my WBC droped from 36.5 to 7.1. My doctor told to come for additional test in two weeks. Now my WBC is 1.3 and absolute neutrophils count is 0.04. I was told to stay home on antibiotics. How long it may take for my counts to clime back to safe range. And of course, I'm off gleevec right now. Does it seem that dose of 400mlg is too high for me.
Am on Gleevec 400mg, now having problems with blisters on the palm. What can I do about it?
I was diagnosed last year and was immediatley put on gleevec 400mg/day.At my last consult my metabolic stats had risen,hence blood tests to determine if the gleevec is no longer working.I am still in firstphase and wonder what my options are if the gleevec is no longer an option.Amin pretty good form,just very tired and a lot of bone pain.
I have CML and was treated with Gleevec for 4 years and achieved remission. I have for the past several months been experiencing sudden onset of weakness which last for hours, to days. My blood pressure which has remained under control for several years with atenolol has been running 145/105 and higher for the past three to four months. I have a feeling of fullness in my stomach, and I have sporatic episodes of mild coughing, this occurs maybe once a week.
You might find he starts to be able to tolerate the pill. Gleevec is first choice for treating CML, and if he is doing good in every other way then encourage him that he is doing great.
I hope this helps you. I would be glad to help you with any other questions.
i get my heart checked every 2 weeks now and i am fine with the qt thing. i take the chemo pill called gleevec and have to force myself to eat so i dont get sick when i take it. how long will these withdrawel problems go on? i have xanax to take (1mg) but dont work to good. i should would appreciate any advice from any one on how to deal with these issues, family dr says its anxiety but i think its the withdrawels from the high dose of elavil.
t have to play any games and risk the SEC bringing charges of holding back to barely change share prices (Vertex virtually unchanged share price since 12-06.). The big stock rise will happen after approval of each section and again more after it shows some real world success. The officers and shareholders all recognize this fact. When that happens the planet will be throwing money at them, so I have to disagree with your conspiracy theory.
Audience share for the these stations now covers the possible market share. Radio audience percentages have fallen off slightly in the past decade, however 93 percent of citizens in the U.S. claim to listen to radio at least once per day. Arbitron shows that of 287 (possible) radio markets, the top six media companies together account for reaching 100 percent of the listening audience in 2004.
Does radio ownership matter to listeners? Perhaps not.
We can only imagine how far AbbVie has to go on price with their pack of pills to have any [market] share. Depending on patient mix, we believe Harvoni will net about $45,000 per patient in 2015 and Sovaldi will net about $54,000… We think investors would suffer the discount happily if assure of price stability beyond 2015, but the bigger concern will be around how much further price can go” as other drug makers enter the market.
Great reading by Liz Peak, says it all, the concerns that the stock market fell to 779 yesterday the lowest since 2002 ,its not onlt the rich people who own stocks,good point eventhe Homeless rely on the charities, and what about the pension plans., The piece that said Most Americans pay their mortgages,92% was quoted, why should they bail out their neighbours?
But Incivek had been widely predicted to garner a bigger share of the market, thanks to data showing a 79% cure rate and to the possibility of even shorter treatment. Plus, Incivek is considered easier to use.
As Reuters notes, more than 3,000 patients had started on Incivek by mid-July, with a mix of people who had failed on older drugs and those who were new to hep C therapy.
Im thinking of the implant but what worries me is the weight gain side effect. Should i get it??? Anyone that has it please share your expierence!
First time we found him standing on the street and second time we found him at the market trying to buy a chocolate without money. He makes me really worried. I told him that if he goes out those scary monster will eat him but he did not became scared and again tried to go out.
If someone have an idea to stop him from going out alone without an elder person,please share.
Thank you.
I was in the fish market last three weeks ago for our one week supply of food..
I was way home and hit my feet with concrete of electrical post in our place. When i was hit i check the concrete and i did not see any needle on it..there's a small wound on my feet with small blood on it...when i reached my house i clean the fish and accidentally prick my fish with his pin..Now it is three weeks and since that day may hearth did not stop for palpitation..
They are expected to come to the market at similar times and be widely used, creating a market share battle. Merck said in early January that it was granted a six-month review; Vertex is getting a similar review and expects a decision by May 23.
Many on Wall Street believe that clinical trials show Vertex's telaprevir is the preferable drug, although Merck's Chief Executive Kenneth Frazier has repeatedly stated his confidence in boceprevir's prospects.
Recommended
